tiprankstipranks
Oncotelic Therapeutics (OTLC)
OTHER OTC:OTLC
US Market

Oncotelic Therapeutics (OTLC) Ownership - Who Owns Oncotelic Therapeutics?

75 Followers

Oncotelic Therapeutics (OTLC) Ownership Overview

51.06%0.00%0.00%48.94%
51.06% Insiders
0.00% Other Institutional Investors
48.94% Public Companies and
Individual Investors
The ownership structure of Oncotelic Therapeutics (OTLC) stock is a mix of institutional, retail and individual investors. Approximately 0.00% of the company’s stock is owned by Institutional Investors, 51.06% is owned by Insiders and 48.94% is owned by Public Companies and Individual Investors.
The ownership structure of Oncotelic Therapeutics (OTLC) stock is a mix of institutional, retail and individual investors. Approximately 0.00% of the company’s stock is owned by Institutional Investors, 51.06% is owned by Insiders and 48.94% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 30, 2023
Vuong Trieu
Chairman & Ceo,director, >10% Owner
Bought$10000
Jun 20, 2023
Vuong Trieu
Chairman & Ceo,director, >10% Owner
Bought$2000
Jun 16, 2023
Vuong Trieu
Chairman & Ceo,director, >10% Owner
Bought$12000
May 31, 2023
Vuong Trieu
Chairman & Ceo,director, >10% Owner
Bought$3807

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
625,747Insider0.16%25,656
300,000Insider0.08%12,300
132,106Insider0.03%5,416
122,000Insider0.03%5,002
18,611Insider<0.01%763
8,761Insider<0.01%359

Top Mutual Fund Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

Top ETF Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Oncotelic Therapeutics (OTLC)?
According to the latest TipRanks data, approximately 0.00% of the company's stock is held by institutional investors, 51.06% is held by insiders, and 48.94% is held by retail investors.
    What percentage of Oncotelic Therapeutics (OTLC) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.00% of Oncotelic Therapeutics (OTLC) stock is held by institutional investors.
      What percentage of Oncotelic Therapeutics (OTLC) stock is held by retail investors?
      According to the latest TipRanks data, approximately 48.94% of Oncotelic Therapeutics (OTLC) stock is held by retail investors.
        Who owns the most shares of Oncotelic Therapeutics (OTLC)?
        William Schwieterman owns the most shares of Oncotelic Therapeutics (OTLC).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis